Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency

被引:21
作者
Allenet, B.
Chen, C.
Romanet, T.
Vialtel, P.
Calop, J.
机构
[1] CHU Grenoble, Dept Pharm, F-38043 Grenoble 9, France
[2] Grenoble Teaching Hosp, Dept Nephrol, Grenoble, France
[3] Univ Grenoble 1, CNRS, Grenoble Teaching Hosp, Dept Pharm,ThEMAS TIMC IMAG,UMR 5525, Grenoble, France
来源
PHARMACY WORLD & SCIENCE | 2007年 / 29卷 / 01期
关键词
patient education; erythropoietin; chronic renal insufficiency; haemoglobin level; compliance; clinical pharmacist;
D O I
10.1007/s11096-005-4800-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Assessment of a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency. Setting: Nephrology Department, Grenoble Hospital, France Method: A 12-week prospective study, using a before-after intervention design. Included in the study were predialysis outpatients with a haemoglobin level < 10 g/dl, de novo EPO prescription; judged qualified by the nephrologist for self-injections; accepting self-injections. The intervention was a single one-hour individual session between the pharmacist and the patient to target (1) medical and therapeutic information; (2) information on the device, a pen used with a cartridge of beta epoietin; (3) training with the pen; and (4) self-injection of the first dose by the patient, in front of the pharmacist. Main outcome measures were knowledge (7-item questionnaire); handling skills (observation) and Quality of Life (1 Likert scale on apprehension towards self-injections and 3 Linear Analog Scales on energy, daily activities, and general well-being); compliance (self-report on self-administered injections) and haemoglobin level. Results: Ten patients were followed for 3 months after intervention. The evolution of the knowledge was positive but not statistically significant after the programme (80% of good answers before; 93% 3 months later). Concerning the patients' skills, difficulties with the pen were important at inclusion, (1) to reset the pen into zero position (2.8 tries/patient +/- 1.8); (2) to insert a new cartridge (1.9 +/- 1.1); and (3) to take air out of the cartridge (2.3 +/- 1.2). After the session, results were satisfactory, since 3 months later, all patients were still on self-injections. QoL improved significantly over the study period respectively on energy, daily activities, and general well-being. The mean level of compliance remained above 90% at 3 months for 8 out of 10 patients. Patients reached the haemoglobin target value of 11 g/dl during the second month of treatment. Conclusion: A tailored educational programme conducted by a pharmacist is beneficial for anaemia patients with chronic renal insufficiency. The programme seems to result in a high level of compliance, leading to an optimal haemoglobin level within two months.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 15 条
[1]   Use of erythropoietin before the initiation of dialysis and its impact on mortality [J].
Fink, JC ;
Blahut, SA ;
Reddy, M ;
Light, PD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (02) :348-355
[2]   Current management of anemia in adult hemodialysis patients with end-stage renal disease [J].
Frankenfield, DL ;
Johnson, CA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (05) :429-435
[3]   Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing [J].
Gabrilove, JL ;
Cleeland, CS ;
Livingston, RB ;
Sarokhan, B ;
Winer, E ;
Einhorn, LH .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2875-2882
[4]  
Gallar Ruiz Paloma, 2000, Clinical Drug Investigation, V20, P151
[5]   Patient education: can it maximize the success of therapy? [J].
Golper, T .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 :20-24
[6]   Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients [J].
Jungers, P ;
Choukroun, G ;
Oualim, Z ;
Robino, C ;
Nguyen, AT ;
Man, NK .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (02) :307-312
[7]   Impact of an education program on patient behaviour favoring prevention of drug-related adverse events;: a pilot study in patients receiving oral anticoagulants for thromboembolic venous disease. [J].
Léger, S ;
Allenet, B ;
Pichot, O ;
Figari, G ;
Calop, J ;
Carpentier, P ;
Bosson, JL .
JOURNAL DES MALADIES VASCULAIRES, 2004, 29 (03) :152-158
[8]  
LINH L, 2001, AM J HEALTH-SYST PH, V58, P2061
[9]  
Nicoletta P, 2000, Adv Perit Dial, V16, P90
[10]  
RADERMACHER J, 1995, CLIN NEPHROL, V44, pS56